These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12196117)

  • 1. Development and potential of non-peptide antagonists for calcitonin-gene-related peptide (CGRP) receptors: evidence for CGRP receptor heterogeneity.
    Wu D; Doods H; Arndt K; Schindler M
    Biochem Soc Trans; 2002 Aug; 30(4):468-73. PubMed ID: 12196117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
    Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
    Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.
    Gupta S; Mehrotra S; Villalón CM; Garrelds IM; de Vries R; van Kats JP; Sharma HS; Saxena PR; Maassenvandenbrink A
    Eur J Pharmacol; 2006 Jan; 530(1-2):107-16. PubMed ID: 16375887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [(3)H]BIBN4096BS.
    Schindler M; Doods HN
    Eur J Pharmacol; 2002 May; 442(3):187-93. PubMed ID: 12065071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.
    Arulmani U; Schuijt MP; Heiligers JP; Willems EW; Villalón CM; Saxena PR
    Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):291-7. PubMed ID: 15228501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.
    Edvinsson L; Alm R; Shaw D; Rutledge RZ; Koblan KS; Longmore J; Kane SA
    Eur J Pharmacol; 2002 Jan; 434(1-2):49-53. PubMed ID: 11755165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig.
    Kapoor K; Arulmani U; Heiligers JP; Willems EW; Doods H; Villalón CM; Saxena PR
    Eur J Pharmacol; 2003 Aug; 475(1-3):69-77. PubMed ID: 12954361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow.
    Tröltzsch M; Denekas T; Messlinger K
    Eur J Pharmacol; 2007 May; 562(1-2):103-10. PubMed ID: 17349622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay.
    Hershey JC; Corcoran HA; Baskin EP; Salvatore CA; Mosser S; Williams TM; Koblan KS; Hargreaves RJ; Kane SA
    Regul Pept; 2005 Apr; 127(1-3):71-7. PubMed ID: 15680472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)(2, 7)]hCGRP-preferring receptor.
    Wu D; Eberlein W; Rudolf K; Engel W; Hallermayer G; Doods H
    Eur J Pharmacol; 2000 Jul; 400(2-3):313-9. PubMed ID: 10988349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells.
    Hay DL; Howitt SG; Conner AC; Doods H; Schindler M; Poyner DR
    Br J Pharmacol; 2002 Sep; 137(1):80-6. PubMed ID: 12183333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
    Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
    Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
    Edvinsson L; Nilsson E; Jansen-Olesen I
    Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations in using peptide drugs to characterize calcitonin gene-related peptide receptors.
    Waugh DJ; Bockman CS; Smith DD; Abel PW
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1419-26. PubMed ID: 10336535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preclinical pharmacology of BIBN4096BS, a CGRP antagonist.
    Hay DL; Poyner D
    Cardiovasc Drug Rev; 2005; 23(1):31-42. PubMed ID: 15867946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists.
    Powell KJ; Ma W; Sutak M; Doods H; Quirion R; Jhamandas K
    Br J Pharmacol; 2000 Nov; 131(5):875-84. PubMed ID: 11053206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and functional pharmacological characteristics of gepant-type antagonists in rat brain and mesenteric arteries.
    Sheykhzade M; Amandi N; Pla MV; Abdolalizadeh B; Sams A; Warfvinge K; Edvinsson L; Pickering DS
    Vascul Pharmacol; 2017 Mar; 90():36-43. PubMed ID: 28192258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS blocks CGRP and adrenomedullin vasoactive responses in the microvasculature.
    Grant AD; Tam CW; Lazar Z; Shih MK; Brain SD
    Br J Pharmacol; 2004 Aug; 142(7):1091-8. PubMed ID: 15237099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1.
    Hay DL; Christopoulos G; Christopoulos A; Sexton PM
    Mol Pharmacol; 2006 Dec; 70(6):1984-91. PubMed ID: 16959943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.
    Petersen KA; Lassen LH; Birk S; Lesko L; Olesen J
    Clin Pharmacol Ther; 2005 Mar; 77(3):202-13. PubMed ID: 15735614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.